Reviewing Outlook Therapeutics Inc. (OTLK)’s and Global Cord Blood Corporation (NYSE:CO)’s results

As Biotechnology companies, Outlook Therapeutics Inc. (NASDAQ:OTLK) and Global Cord Blood Corporation (NYSE:CO) are our subject to contrast. And more specifically their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Outlook Therapeutics Inc. 3.38M 10.19 40.18M -0.90 0.00
Global Cord Blood Corporation N/A 0.00 N/A 0.28 26.39

Demonstrates Outlook Therapeutics Inc. and Global Cord Blood Corporation earnings per share, top-line revenue and valuation.


Table 2 has Outlook Therapeutics Inc. and Global Cord Blood Corporation’s return on equity, return on assets and net margins.

Net Margins Return on Equity Return on Assets
Outlook Therapeutics Inc. -1,188.76% 158.6% -156.3%
Global Cord Blood Corporation 0.00% 7.2% 3.8%


The Current Ratio and Quick Ratio of Outlook Therapeutics Inc. are 0.1 and 0.1 respectively. Its competitor Global Cord Blood Corporation’s Current Ratio is 9.7 and its Quick Ratio is 9.6. Global Cord Blood Corporation can pay off short and long-term obligations better than Outlook Therapeutics Inc.


On the other side, $0.08 per share with a dividend yield of 1.06% for Global Cord Blood Corporation. Outlook Therapeutics Inc. does not pay a dividend.

Institutional and Insider Ownership

Institutional investors held 4.8% of Outlook Therapeutics Inc. shares and 17.4% of Global Cord Blood Corporation shares. 7.8% are Outlook Therapeutics Inc.’s share held by insiders. Insiders Competitively, held 49.6% of Global Cord Blood Corporation shares.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Outlook Therapeutics Inc. 3.7% 46.4% 65.44% 25.98% -1.75% 124%
Global Cord Blood Corporation 3.79% 17.68% 15.29% 6.79% -29.82% 14.57%

For the past year Outlook Therapeutics Inc. has stronger performance than Global Cord Blood Corporation


Global Cord Blood Corporation beats on 7 of the 11 factors Outlook Therapeutics Inc.

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.